GL1X · GenesisL1 explorer

Research workbench

T4 phage bgt-D100A mutant in complex with udp-glucose: form II

Analyse T4 phage bgt-D100A mutant in complex with udp-glucose: form II in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1NZF
Type
protein
Length
351 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA beta-glycosyltransferase
EC
2.4.1.27
UniProt
P04547
Ligands
UPG, CL
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA beta-glycosyltransferase (EC 2.4.1.27)protein35139% helix, 17% strandP04547

Ligands and binding sites

  • UPG · Uridine-5'-diphosphate-glucose · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14040.770.8638UPG, GOL
21820.540.7925empty
31360.480.7824CL

Compared structures

  • 1NZF · T4 phage BGT-D100A mutant in complex with UDP-glucose: Form II · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.